Elite Pharmaceuticals Inc (ELTP)

[SankaraD]

Sevaral years back, there was an independent evaluation of the stock. At that point, it stood at $2.39 (or was it 2.59). Subsequent to that, there was some dilution (do not remember how much), a couple of generics added to the product line, ANDA filed, Sequestox on the last leg of approval and several more ADT OPIOIDs getting ready to get on to the conveyor belt.

Any guesses or information on what the current valuation should be or going to be?

Just trying to initiate a positive debate.

Thanks in advance for all sensible answers, positive and negative.